Afya (NASDAQ:AFYA – Get Rating) released its earnings results on Monday. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.51 by $0.32, Fidelity Earnings reports. Afya had a return on equity of 7.32% and a net margin of 12.94%. During the same period last year, the business earned $0.21 EPS. Afya updated its FY 2022 guidance to EPS.
Shares of AFYA stock opened at $11.28 on Tuesday. Afya has a 1-year low of $10.64 and a 1-year high of $28.23. The stock’s 50-day moving average is $13.71 and its 200 day moving average is $13.86. The company has a market cap of $1.04 billion, a P/E ratio of 25.64, a PEG ratio of 0.60 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.57 and a quick ratio of 1.56.
A number of hedge funds and other institutional investors have recently modified their holdings of AFYA. Lazard Asset Management LLC acquired a new stake in Afya in the first quarter worth about $30,000. Quantbot Technologies LP acquired a new stake in Afya in the first quarter worth about $30,000. Dynamic Technology Lab Private Ltd acquired a new stake in Afya in the first quarter worth about $180,000. Millennium Management LLC acquired a new stake in Afya in the third quarter worth about $233,000. Finally, Citadel Advisors LLC acquired a new stake in Afya in the fourth quarter worth about $268,000. 57.03% of the stock is owned by institutional investors and hedge funds.
Afya Company Profile (Get Rating)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
- Get a free copy of the StockNews.com research report on Afya (AFYA)
- CrowdStrike: A Cybersecurity Unicorn
- Two Stocks You Shouldn’t Buy On Post-Earnings Weakness
- Texas Roadhouse Stock Looks Sizzling Down Here
- Time to Bid Low for Farfetch Stock
- Don’t Wait Too Long to Buy These 3 Mega Caps
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.